Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

BACKGROUND: Androgen-deprivation therapy (ADT) has been the backbone of treatment for metastatic prostate cancer since the 1940s. We assessed whether concomitant treatment with ADT plus docetaxel would result in longer overall survival than that with ADT alone. METHODS: We assigned men with metastat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:N Engl J Med
Main Authors: Sweeney, Christopher J., Chen, Yu-Hui, Carducci, Michael, Liu, Glenn, Jarrard, David F., Eisenberger, Mario, Wong, Yu-Ning, Hahn, Noah, Kohli, Manish, Cooney, Matthew M., Dreicer, Robert, Vogelzang, Nicholas J., Picus, Joel, Shevrin, Daniel, Hussain, Maha, Garcia, Jorge A., DiPaola, Robert S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4562797/
https://ncbi.nlm.nih.gov/pubmed/26244877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1503747
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados